AJ
Ajooni Biotech Ltd (AJOONI)
₹3.11
Mkt cap
₹57 Cr
P/E ratio
14.30
P/B
0.59
Div yield
0.00%
ROE
4.28%
ROCE
6.11%
EPS (TTM)
₹0.22
Book value
₹5
52W range
3–6
Sector
Fast Moving Consumer Goods
Price history
Previous close
Incorporated in 2010, Ajooni Biotech Ltd is a vegetarian based animal health care solutions company. [1]
NSE AJOONI
Health check
Mixed
ValuationCheap
ProfitabilityWeak
GrowthHigh
TechnicalsBearish
52-week range
−44.17% from high₹3
₹3+3.67% from low₹6
Current
₹3.11
Prev close
₹3.09
Day
+0.65%
Price performance
1D
+0.65%
1W
−0.96%
1M
−16.17%
3M
−18.16%
6M
−23.21%
1Y
−41.21%
YTD
−28.18%
Financials
Revenue, profit & margin
P/E ratio
14.3×
AJOONI is 28% below the sector median of 19.9×
AJOONI14.3×
Sector median19.9×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.00 | 19.48 | 20.05 | 19.58 | 25.66 | 25.72 | 34.03 | 29.27 | 31.27 | 31.74 | 58.75 | 60.62 | 63.49 | |
| Expenses | 20.34 | 18.85 | 20.70 | 17.99 | 24.70 | 24.95 | 33.10 | 28.26 | 30.56 | 30.24 | 55.72 | 59.61 | 61.82 | |
| Operating Profit | 0.66 | 0.63 | -0.65 | 1.59 | 0.96 | 0.77 | 0.93 | 1.01 | 0.71 | 1.50 | 3.03 | 1.01 | 1.67 | |
| OPM % | 3.14% | 3.23% | -3.24% | 8.12% | 3.74% | 2.99% | 2.73% | 3.45% | 2.27% | 4.73% | 5.16% | 1.67% | 2.63% | |
| Other Income | 0.07 | 0.29 | 1.57 | 0.26 | 0.04 | 0.31 | 0.39 | 1.34 | 0.65 | 0.15 | 0.32 | 1.30 | 0.27 | |
| Interest | 0.13 | 0.19 | 0.12 | 0.11 | 0.15 | 0.06 | 0.07 | 0.06 | 0.08 | 0.17 | 0.18 | 0.29 | 0.48 | |
| Depreciation | 0.21 | 0.21 | 0.21 | 0.24 | 0.22 | 0.23 | 0.24 | 0.38 | 0.25 | 0.25 | 0.81 | 0.90 | 0.80 | |
| Profit before tax | 0.39 | 0.52 | 0.59 | 1.50 | 0.63 | 0.79 | 1.01 | 1.91 | 1.03 | 1.23 | 2.36 | 1.12 | 0.66 | |
| Tax % | -2.56% | 23.08% | 23.73% | 38.67% | 25.40% | 22.78% | 27.72% | 19.37% | 24.27% | 24.39% | 30.08% | 15.18% | 34.85% | |
| Net Profit | 0.40 | 0.40 | 0.44 | 0.91 | 0.47 | 0.62 | 0.73 | 1.54 | 0.78 | 0.93 | 1.65 | 0.95 | 0.43 | |
| EPS in Rs | 0.02 | 0.02 | 0.03 | 0.05 | 0.03 | 0.04 | 0.04 | 0.09 | 0.05 | 0.05 | 0.10 | 0.06 | 0.02 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −1.30% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 14 Aug '26◦ |
| Earnings day | −1.30% |
| +1 day | −1.04% |
| +5 days | −2.85% |
| +15 days | −9.59% |
| +30 days | −18.65% |
| Filing |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Aug 202630.53%Promoter
Promoters30.53%3.64
FIIs0.00%
Public69.47%3.64
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Godrej Agrovet | ₹661.60 | 27.13 | 12,730 | 1.66% | 128 | −16.21% | 2,855 | +9.22% | 19.16% |
| Avanti Feeds | ₹774.45 | 19.61 | 10,552 | 1.29% | 116 | −42.00% | 1,900 | +18.32% | 24.38% |
| Mukka Proteins | ₹26.93 | 11.68 | 808 | 0.00% | 19 | +1,142.76% | 490 | +186.73% | 11.61% |
| KSE | ₹178.37 | 12.38 | 571 | 7.01% | 1 | −98.44% | 454 | +9.06% | 33.55% |
| Shivam Chemicals | ₹117.50 | 33.38 | 200 | 0.00% | 4 | +163.87% | 153 | +17.61% | 16.65% |
| Mayank Cattle Fo | ₹111.00 | 19.91 | 120 | 0.00% | 3 | +18.31% | 218 | +2.91% | 15.85% |
| Narmada Agrobase | ₹13.72 | 29.00 | 104 | 0.00% | 1 | −26.47% | 22 | +100.90% | 8.95% |
| Ajooni Biotech | ₹3.28 | 14.27 | 57 | 0.00% | 0 | −44.87% | 63 | +103.04% | 6.11% |
| Median: 7 Co. | ₹117.50 | 19.91 | 571 | 0.00% | 4 | −16.21% | 454 | +17.61% | 16.65% |
Filings
Annual reports6
Concall transcripts6
Credit ratings6
Announcements5
Outcome of Board Meeting 14 Aug - Ajooni Biotech approved Q1 FY27 results ended 30 June 2026; net profit was ₹43.18 lakh.Outcome of Board Meeting 14 Aug - Board approved Q1 FY27 unaudited results; revenue Rs 63.76 crore, net profit Rs 43.18 lakh.Allotment of Securities 12 Aug - Board approved preferential allotment of 90 lakh equity shares at ₹4.30 on August 12, 2026.Increase in Authorised Capital 31 Jul - Members approved increase in authorised share capital to Rs. 70 crore at the 16th AGM.Issue of Securities 31 Jul - Members approved issuance of 90,00,000 equity shares at Rs. 4.30 each on July 29, 2026.

